Vitamin D Supplements for HIV-positive Patients on cART
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The ability of vitamin D to modulate the immune system and strengthen bones may mitigate the
adverse medication consequences of HIV/AIDS, but little is known about either the health
benefits of vitamin D supplements, or about the optimal dosing regimen for patients on highly
active antiretroviral therapy (HAART). This trial is a comparison of two regimens for
administering vitamin D and calcium to HIV-positive individuals taking antiviral medications.
This study will help physicians make evidence-based decisions about the most effective way to
use vitamin D in their patients and enable the design of large multi-center trials in the
future.
Phase:
N/A
Details
Lead Sponsor:
Andrea Branch
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins